ACA
RDY icon

Atlas Capital Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Atlas Capital Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,440
Closed -$70.1K – 1011
2024
Q4 		$70.1K Hold
4,440
– – 0.01% 557
2024
Q3 		$70.6K Buy
4,440
+530
+14% +$8.53K 0.01% 533
2024
Q2 		$59.6K Hold
3,910
– – 0.01% 564
2024
Q1 		$57.4K Hold
3,910
– – 0.01% 554
2023
Q4 		$54.4K Hold
3,910
– – 0.01% 575
2023
Q3 		$52.3K Buy
+3,910
New +$52.9K 0.01% 533

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Atlas Capital Advisors's RDY Position: Q1 2025 in Review

Atlas Capital Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 4,440 shares — an estimated $70.1K sold.

Atlas Capital Advisors first reported a position in RDY in Q3 2023 and held it in 6 quarters. The position peaked at $70.6K in Q3 2024. 246 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Atlas Capital Advisors reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Atlas Capital Advisors sold 4,440 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $70.1K.
  • Atlas Capital Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 6 quarters.
  • Atlas Capital Advisors's Dr. Reddy's Laboratories position peaked at $70.6K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Atlas Capital Advisors's 13F filing for Q1 2025, filed 12 May 2025.